Articles with "nab responses" as a keyword



Photo from wikipedia

Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA Oncology"

DOI: 10.1001/jamaoncol.2022.0446

Abstract: Key Points Question Are there differences in the magnitude and durability of neutralizing antibody (nAb) responses against SARS-CoV-2 variants of concern (VOCs) according to the mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) vaccines? Findings In this comparative… read more here.

Keywords: mrna; variants concern; immunocompromised patients; nab responses ... See more keywords
Photo from wikipedia

Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic Sera

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of Virology"

DOI: 10.1128/jvi.00404-21

Abstract: Widespread immunity to SARS-CoV-2 will be necessary to end the COVID-19 pandemic. NAb responses are a critical component of immunity that can be stimulated by natural infection as well as vaccines. ABSTRACT Emerging SARS-CoV-2 variants… read more here.

Keywords: cov variants; cross neutralization; early pandemic; sars cov ... See more keywords
Photo from wikipedia

Prominent Neutralizing Antibody Response Targeting the Ebolavirus Glycoprotein Subunit Interface Elicited by Immunization

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of Virology"

DOI: 10.1128/jvi.01907-20

Abstract: The elicitation of sustained neutralizing antibody (nAb) responses against diverse ebolavirus strains remains a high priority for the vaccine field. The most clinically advanced rVSV-ZEBOV vaccine could elicit moderate nAb responses against only one ebolavirus… read more here.

Keywords: immunization; ebolavirus; neutralizing antibody; interface ... See more keywords

Neutralizing Antibodies Induced by First-Generation gp41-Stabilized HIV-1 Envelope Trimers and Nanoparticles

Sign Up to like & get
recommendations!
Published in 2021 at "mBio"

DOI: 10.1128/mbio.00429-21

Abstract: Self-assembling protein nanoparticles (NPs) presenting BG505 envelope (Env) trimers can elicit tier 2 HIV-1-neutralizing antibody (NAb) responses more effectively than soluble trimers. In the present study, monoclonal NAbs were isolated from previously immunized mice and… read more here.

Keywords: gp41 stabilized; bg505 env; envelope; env ... See more keywords